Opioid responsiveness-primary diagnosis relationship in advanced cancer patients followed at home

Journal of Pain and Symptom Management

Volumn 20, Issue 1, 2000, Pages 27-34

  Mercadante, Sebastiano ^a,b   Casuccio, Alessandra ^c   Pumo, Salvatore ^a   Fulfaro, Fabio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Pain Relief and Palliative Care   (Italy)

^c LA MADDALENA CANCER CENTER   (Italy)

Author keywords

Home care; Opioid responsiveness; Primary diagnosis relationship; Prospective epidemiologic study

Indexed keywords

DEXTROPROPOXYPHENE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PAIN; COLORECTAL CANCER; DRUG RESPONSE; HEAD AND NECK CANCER; HOME CARE; HUMAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MESOTHELIOMA; PANCREAS CANCER; PROSTATE CANCER; STOMACH CANCER; UTERUS CANCER; VISCERAL PAIN;

ANALGESICS, OPIOID; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES;

EID: 0033856905     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00145-7     Document Type: Article

References (22)

1. Collin E., Poulain P., Gauvain-Piquard A., Petit G., Pichard-Leandri E. Is disease progression the major factor in morphine tolerance in cancer pain treatment? Pain. 55:1993;319-326.
2. Grond S., Zech D., Diefenbach C., Bischoff A. Prevalence and pattern of symptoms in pateints with cancer pain. a prospective evaluation of 1635 cancer patients referred to a pain clinic J Pain Symptom Manage. 9:1994;372-382.
3. Arcuri E. Can tumors act as opioid traps, miming opioid tolerance? J Pain Symptom Manage. 16:1998;78-79.
4. Vainio A. Prevalence of symptoms in cancer. Palliat Med. 5:1991;275-276.
5. Mercadante S., Dardanoni G., Salvaggio L., Armata M.G., Agnello A. Monitoring of opioid therapy in advanced cancer pain patients. J Pain Symptom Manage. 13:1997;204-212.
6. Hanks G.W., De Conno F., Ripamonti C., Ventafridda V., Hanna M., McQuay H.J., Mercadante S., Meynadier J., Poulain P., Roca J., Casas J., Sawe J., Twycross R.G., Vainio A., Zech D. Morphine in cancer pain. modes of administration Br Med J. 312:1996;823-826.
7. Hanks G.W., Justins D.M. Cancer pain. management Lancet. 339:1992;1031-1036.
8. Mercadante S. Pain treatment and outcome in advanced cancer patients followed at home. Cancer. 85:1999;1849-1858.
9. Coyle N., Adelhart J., Foley K.M., Portenoy R.K. Character of terminal illness in the advanced cancer patients. pain and other symptoms during the last four weeks of life J Pain Symptom Manage. 5:1990;83-93.
10. Stiefel F. On symptom control when death is near. J Palliat Care. 7:1991;39-41.
11. Vainio A., Auvinen A. Prevalence of symptoms among patients with advanced cancer. an international collaborative study J Pain Symptom Manage. 12:1996;3-10.
12. Grond S., Zech D., Diefenbach C., Radbruch L., Lehmman K.A. Assessment of cancer pain. a prospective evaluation in 2266 cancer patients referred to a pain service Pain. 64:1996;107-114.
13. Mercadante S. Pain responsiveness in patients with advanced head and neck cancer. Support Care Cancer. 6:1998;482-485.
14. Leclercq R.M., Jongmans-Liedekerken A.W. Malignant pleural mesothelioma in general practice. complex pain problems Ned Tijdschr Geneeskd. 141:1997;1081-1085.
15. Portenoy R.K., Foley K.M., Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain. new hypotheses derived from studies of opioid infusions Pain. 43:1990;273-286.
16. Mystakidou K., Befon S., Liossi C., Vlachos L. Comparison of tropisetron and chrorpomazine combinations in the control of nausea and vomiting in patients with advanced cancer. J Pain Symptom Manage. 15:1998;176-184.
17. Zech D.F.J., Grond S., Lynch J., Hertel D., Lehmann K.A. Validation of World Health Organization guidelines for cancer pain relief. a 10-year prospective study Pain. 63:1995;65-76.
18. Johnson J.T., Ferretti G.A., Netherny W.J., Valdez I.H., Fox P.C., Ng D., Muscoplat C.C., Gallagher S.C. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 329:1993;390-395.
19. Bruera E., MacMillan D., Hanson J., MacDonald R.N. The Edmonton staging system for cancer pain. preliminary report Pain. 37:1989;203-210.
20. Portenoy R.K., Foley K.M., Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain. new hypothesies derived from studies of opioid infusions Pain. 43:1990;273-286.
21. Mercadante S, Portenoy RK. Opioid poorly responsive cancer pain. Part 1. Clinical consideration. J Pain Symptom Manage, in press.
22. Mercadante S. Predictive factors and opioid responsiveness in cancer pain. Eur J Cancer. 34:1998;627-631.